Similarly, emerging research suggests that tRNA‐derived small RNAs, such as tsRNA‐GlyGCC, modulate oncogenic signaling pathways in CRC and contribute to chemoresistance by targeting SPIB within the JAK1/STAT6 pathway [20]. This evidence concerns the gene JAK1 and colorectal carcinoma.